Tomoyuki Mizuno

Tomoyuki Mizuno

Cincinnati Children's Hospital Medical Center - Cincinnati / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4620334
person_outline Tomoyuki Mizuno's MOST POPULAR ARTICLES
1-) Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus reportM Brunet, T Van Gelder, A Åsberg, V Haufroid, DA Hesselink, L Langman, ...Therapeutic drug monitoring 41 (3), 261-307, 20192952019
2-) Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancerY Togashi, K Masago, S Masuda, T Mizuno, M Fukudo, Y Ikemi, ...Cancer chemotherapy and pharmacology 70 (3), 399-405, 20122722012
3-) Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metforminM Tsuda, T Terada, T Mizuno, T Katsura, J Shimakura, K InuiMolecular pharmacology 75 (6), 1280-1286, 20092022009
4-) Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working groupKLR Brouwer, LM Aleksunes, B Brandys, GP Giacoia, G Knipp, ...Clinical Pharmacology & Therapeutics 98 (3), 266-287, 20151862015
5-) Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicologyS Bergan, M Brunet, DA Hesselink, KL Johnson-Davis, PK Kunicki, ...Therapeutic drug monitoring 43 (2), 150-200, 20211532021